Your COVID-19 update for October 29, 2021

A trial involving roughly 1,500 patients found that those who took an inexpensive drug called fluvoxamine were significantly less likely to progress to severe COVID-19 disease and require hospitalization, according to the Associated Press.

Commentaires

Posts les plus consultés de ce blog

This Is What Fish Oil Supplements Actually Do

Chris Froome sends out strong message to his rivals as he storms back to win Criterium du Dauphine for the second time

Kid draws a hilarious family portrait, featuring his mother on her period